Anadis

Anadis is a biotechnology company based in Melbourne, Australia that trades on the Australian Stock Exchange with the symbol IMC.[1] an ADR Level I program was initiated in late 2007, and the company is quoted over the counter in the U.S. with the ticker ANDIY

The company focused on antigen-primed, dairy-derived health products. Anadis’ proprietary, technology enables it to rapidly develop polyclonal antibody and other proteins-based solutions to a range of important diseases.

Anadis specialises in nutraceutical, pharmaceutical and related therapeutic technology products, including Oral and GI Mucositis, Routine and Avian Influenza, - E. coli Travellers' diarrhoea (TD), Irritable Bowel Syndrome (IBS) and Inflammatory Bowel Disease (IBD), and Anthrax containment.

External links

References

  1. ↑ "Anadis". Australian Stock Exchange. 2007-06-05.


This article is issued from Wikipedia - version of the 10/16/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.